People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. | — | Biotechnology | Series D+ | $231.8M | $369.9M | 2023 |
| Protego Biopharma | — | Biotechnology | Series C | $85.0M | $179.4M | 2025 |
Brent J. Warner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brent J. Warner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Hirsch | 1 | 16 |
| Shelley Chu | 1 | 10 |
| Mark Gergen | 1 | 3 |
| Lars Ekman | 1 | 2 |
| Charles M. Baum | 1 | 2 |
| Edward Hurwitz | 1 | 2 |
| Helen Kim | 1 | 2 |
| Jeffery W. Kelly | 1 | 2 |
| EDWARD J. HURWITZ | 1 | 2 |
| SHELLEY J. CHU | 1 | 2 |
| HELEN J. KIM | 1 | 2 |
| Jeffrey Kelly | 1 | 2 |
| Catherine J. Mackey | 1 | 2 |
| Mark J. Gergen | 1 | 2 |
| LAURA J. BRASS | 1 | 1 |
| JEFFERY J. KELLY | 1 | 1 |
| Marcea Bland Lloyd | 1 | 1 |
| Sean J. Murphy | 1 | 1 |
| Richard Labaudiniere | 1 | 1 |
| Matthew Spear | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.